Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1500 participants
INTERVENTIONAL
2020-02-03
2028-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1). National feasibility and safety study. 2). National multicenter registry-based cluster randomized crossover clinical trial (RRCT).
1. In the feasibility study, patients will be offered remote exCR at all participating sites until the peak of the pandemic has been achieved and care goes back to normal. The feasibility study will include patients until Aug 2022.
2. CR centers (not patients) will be cluster randomized to either the intervention or control. Patients at intervention centers will be offered remote exCR, usual care centre-based exCR, or a combination of both modes, as self-preferred choice. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be 15 months. Long-term follow-up will be performed 1 year and 3 years after the index cardiac event.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention center
Patients at intervention centers will be offered remote video exCR (first-hand option), usual care centre-based exCR or a combination. The exercise program (remote/centre-based) will be standardized and performed for totally 60 minutes, 2 times a week for 3 months. Exercise will be individually prescribed and progressed by physiotherapists in accordance with guidelines. Patients will also be asked to perform one additional session of at least 30 min aerobic exercise per week, at intensity level 13-15 according to Borg RPE-scale.
Exercise-based cardiac rehabilitation
The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.
Control
At control centers, patients will be offered usual care centre-based exCR only. Patients will also be asked to perform one additional session of at least 30 min aerobic exercise per week, at intensity level 13-15 according to Borg RPE-scale.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise-based cardiac rehabilitation
The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of type 1 myocardial infarction (AMI)
* Age 18-79 years at discharge from hospital
Exclusion Criteria
* Severe valve or structural heart disease
* Severe heart failure (NYHA III - IV)
* Serious arrythmias
* Inability to understand Swedish
* No internet access at home (only applicable for patients in the intervention group who wants to perform remote exCR)
* Pathological exercise test indicating high risk for adverse events during exCR
* More than 6 months between discharge form hospital and screening
* Any other condition that may interfere with the possibility for the patient to comply with the study protocol
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Bäck
Associate professor, physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Back, Ass Prof
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital
Stefan James, Prof
Role: STUDY_CHAIR
Uppsala Clinial Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Södra Älvsborg Hospital
Borås, , Sweden
Mälarsjukhuset
Eskilstuna, , Sweden
Falun hospital
Falun, , Sweden
Gällivare Hospital
Gällivare, , Sweden
Gävle Hospital
Gävle, , Sweden
Angered Hospital
Gothenburg, , Sweden
Sahlgrenska University Hospital Östra
Gothenburg, , Sweden
Sahlgrenska University Hospital
Gothenburg, , Sweden
Hässleholm Hospital
Hässleholm, , Sweden
Jönköping Ryhov hospital
Jönköping, , Sweden
Kalix hospital
Kalix, , Sweden
Kalmar Hospital
Kalmar, , Sweden
Kungälv Hospital
Kungälv, , Sweden
Lindesberg Hospital
Lindesberg, , Sweden
Linköping University Hospital
Linköping, , Sweden
Ljungby Hospital
Ljungby, , Sweden
Sunderbyn hospital
Luleå, , Sweden
Skåne University hospital
Lund, , Sweden
Skåne University Hospital Malmö
Malmo, , Sweden
Östersund hospital
Östersund, , Sweden
Södertälje Hospital
Södertälje, , Sweden
Capio St Göran Hospital
Stockholm, , Sweden
Karolinska University Hospital
Stockholm, , Sweden
Sundsvall hospital
Sundsvall, , Sweden
Uppsala University Hopsital
Uppsala, , Sweden
Värnamo hospital
Värnamo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ellinor Nylund, RPT
Role: primary
Ellinor Nylund, RPT
Role: backup
Annalina Anduri Ohlsson, RPT
Role: primary
Lovisa Wahlen, RPT
Role: primary
Lovisa Wahlen, RPT
Role: backup
Sara Fabricius, RPT
Role: primary
Anna Forsgren, RPT
Role: primary
Aziza Ferreira, RPT
Role: primary
Klara Emanuelsson Hummel, RPT
Role: primary
Maria Bäck, PhD
Role: primary
Maria Back, Ass Prof
Role: backup
Sandra Larsson, RPT
Role: primary
Maria Sahlin, RPT
Role: primary
Maria Sahlin, RPT
Role: backup
Eva Öberg, RPT
Role: primary
Eva Öberg, RPT
Role: backup
Charlotta Lans, PhD
Role: primary
Tina Nyth Persson, RPT
Role: primary
Marcus Bargholtz, MSc
Role: primary
Sabina Borg, RPT
Role: primary
Sabina Borg, RPT
Role: backup
Jessica Olovsson, RPT
Role: primary
Lena Bergström, RPT
Role: primary
Lena Bergström, RPT
Role: backup
Simon Holm, RPT
Role: primary
Simon Holm, RPT
Role: backup
Margret Leosdottir, PhD
Role: primary
Mattias Pettersson, RPT
Role: primary
Mattias Pettersson, RPT
Role: backup
Maria Jäderlund, MSc
Role: primary
Sofia Haghanipour, RPT
Role: primary
Amanda Lönn, PhD
Role: primary
Annika Henriksson
Role: primary
Kajsa Hedin
Role: backup
Charlotte Urell, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Back M, Leosdottir M, Ekstrom M, Hambraeus K, Ravn-Fischer A, Oberg B, Ostlund O, James S. The remote exercise SWEDEHEART study-Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT). Am Heart J. 2023 Aug;262:110-118. doi: 10.1016/j.ahj.2023.04.014. Epub 2023 Apr 25.
Back M, Leosdottir M, Ekstrom M, Hambraeus K, Ravn-Fischer A, Borg S, Brosved M, Flink M, Hedin K, Lans C, Olovsson J, Urell C, Oberg B, James S. Feasibility, safety and patient perceptions of exercise-based cardiac telerehabilitation in a multicentre real-world setting after myocardial infarction-the remote exercise SWEDEHEART study. Eur Heart J Digit Health. 2025 Mar 4;6(3):508-518. doi: 10.1093/ehjdh/ztaf014. eCollection 2025 May.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U-2018-312
Identifier Type: -
Identifier Source: org_study_id